08:15 AM EDT, 07/28/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target price by $25 to $320 using a wider equity risk premium as we anticipate lower interest rates ahead. We apply a forward P/E of 15.1x, which is in line with the historic five-year average at 14.9x and the 10-year average at 15.0x. So, we think JPM's share price can work toward our target price in the next 12 months. As long as JPM can drive revenue and EPS growth in the next 12-18 months, we think P/E multiple expansion is possible. We are less concerned about price/BV or price to NTBV where our target price would equate to multiples of 2.9x and 3.4x, respectively. We think these are lagging valuation metrics, provided we see the Fed pivot to a rate easing regime (rate cuts) and JPM can deliver superior earnings as reflected in our earnings estimates. We increased our 2025 EPS estimate by $1.75 to $20.15 and 2026's by $1.65 to $21.20 on respective revenue projections of $180B (prior $175B) and$190B ($182B). We would wait for share price weakness before re-evaluating our 3-STARS rating.